Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pseudomyxoma Peritonei × Tacrolimus × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 93 Myelodysplastic Syndromes 90 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Lymphoma, Non-Hodgkin 60 Leukemia 60 Multiple Myeloma 59 Hodgkin Disease 59 Leukemia, Lymphocytic, Chronic, B-Cell 56 Lymphoma 54 Myeloproliferative Disorders 43 Graft vs Host Disease 41 Hematologic Neoplasms 40 Lymphoma, Follicular 39 Leukemia, Myeloid, Accelerated Phase 38 Lymphoma, Mantle-Cell 37 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37 Lymphoma, Large B-Cell, Diffuse 36 Leukemia, Myelomonocytic, Chronic 36 Lymphoma, B-Cell, Marginal Zone 34 Congenital Abnormalities 34 Burkitt Lymphoma 34 Primary Myelofibrosis 31 Leukemia, Myeloid, Chronic-Phase 31 Blast Crisis 31 Neoplasms, Plasma Cell 30 Lymphoma, Large-Cell, Immunoblastic 27 Lymphoma, T-Cell, Cutaneous 20 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 20 Waldenstrom Macroglobulinemia 19 Myelodysplastic-Myeloproliferative Diseases 19

Interventions

Mitomycin 3 Hyperthermic Intraperitoneal Chemotherapy 3 Fluorouracil 2 Capecitabine 2 tislelizumab 1 molgramostim 1 irinotecan sucrosofate 1 Tacrolimus 1 Surveys and Questionnaires 1 Sirolimus 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Pharmacogenomic Testing 1 Oxaliplatin 1 Observation 1 Methods 1 Leucovorin 1 Lansoprazole 1 Ifosfamide 1 Gemcitabine 1 Early Intervention, Educational 1 Doxorubicin 1 Cytoreduction Surgical Procedures 1 Clarithromycin 1 Cisplatin 1 Carboplatin 1 Behavior Therapy 1 Amoxicillin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084780 2026-01-23

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡